|
|
|
| A Research on the Relevance of Residual Cholesterol to Acute Coronary Syndrome |
| GAO Tenglong, QIAN Wenru, ZHAO Chunsheng, et al |
| The Affiliated Hospital of Chengde Medical College, Hebei Chengde 067000, China |
|
|
|
|
Abstract Objective: To analyze the changes of residual cholesterol (RC) in patients with acute coronary syndrome (ACS) and study the relevance of RC to ACS. Methods: A total of 300 patients with ACS who were hospitalized in the Department of Cardiology of our hospital from January 2017 to February 2018 were selected as the research objects. According to the diagnostic criteria, ACS patients were sub-grouped: acute ST segment elevation myocardial infarction group (STEMI group), acute non-ST segment elevation myocardial infarction group (NSTEMI group), unstable angina pectoris group (UA group), with 108 cases, 88 cases and 104 cases in each group. 100 patients with chest pain and without ACS were selected and made the non-ACS group. The clinical data of the subjects were collected and the differences of blood lipid levels among the four groups were compared. Results:The levels of total cholesterol (TC), low density lipoprotein cholesterol (LDL-C) and residual cholesterol (RC) in STEMI group, NSTEMI group and UA group were significantly higher than those in non-ACS group (P < 0.05). There was no significant difference in HDL-C and non-HDL-C (P > 0.05). The area under RC curve in ROC was 0.710, which was higher than other blood lipid indexes. Conclusion: RC is associated with acute coronary syndrome, and has a certain predictive value in the diagnosis of acute myocardial infarction.
|
|
|
|
|
|
[1] BuiAH,WaksW.Risk stratification of sudden cardiac death after acute myocardial infarction[J].JInnov Card Rhythm Manag,2018 ,9(2):3035~3049.
[2] Bruzzone G, Corbelli G, Belci P,et al. Cholesterol lowering therapy: treat to target or reduce the global risk. the unresolved problem of residual risk[J]. Curr Pharm Des, 2016,22(37):5676~5686.
[3] Ibanez Borja,James Stefan,Agewall Stefan,et al.2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the european society of cardiology (ESC) [J]. European heart journal,2018, 39(2):119~177 .
[4] Nordestgaard BG, Varbo A .Triglycerides and cardiovascular disease[J]. Lancet ,2014,384:626~635.
[5] Sandesara PB, Virani SS, Fazio S, et al. The forgotten lipids: triglycerides, remnant cholesterol, and atherosclerotic cardiovascular disease risk[J]. Endocr Rev,2019 ,40(2):537~557.
[6] Anette Varbo,Borge G Nordestgaard. Remnant lipoproteins[J]. Curr Opin Lipidol,2017,28(4):300~307.
[7] Georg Goliasch,Franz Wiesbauer,Hermann Blessberger,et al. Premature myocardial infarction is strongly associated with increased levels of remnant cholesterol[J]. Journal of Clinical Lipidology,2015,9(6):801~806.
[8] 商广芸,高燕飞,曹洪波,等.急性心肌梗死的危险因素分析[J].实用临床医药杂志,2020,24(12):48~50. |
|
|
|
2021, Vol. 27 
